JSKN022

· Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JSKN022, covering 2025-12-23 to 2025-12-23. Get the full timeline:

Most recent: Clinical Trial Update: JSKN022 in Subjects With Advanced Malignant Solid Tumors [Phase 1]